Medical Condition News

RSS

Shire announces FDA approval of Vyvanse Capsules for binge eating disorder

Shire plc announced today that the U.S. Food and Drug Administration approved Vyvanse (lisdexamfetamine dimesylate) Capsules (CII), the first and only medication for the treatment of moderate to severe binge eating disorder (B.E.D.) in adults, shown to significantly reduce the mean number of binge days per week.

30 Jan 2015

Using antioxidant to reverse brain inflammation improves obesity, diabetes symptoms

Using an antioxidant to reverse inflammation in the brain caused by a high-fat diet greatly improves symptoms related to obesity and type II diabetes, a new study from New Zealand's University of Otago suggests.

30 Jan 2015

BTH to develop new technologies to improve quality of life for elderly people with mild dementia

Blekinge Institute of Technology in Sweden will receive 10 million SEK to develop new technologies that will increase the quality of life for elderly people with mild dementia. The technology, IT support via e-readers, will also facilitate for the relatives.

30 Jan 2015

UCSD, UCSF launch new project to map cancer cells

Researchers from the University of California, San Diego School of Medicine and University of California, San Francisco, with support from a diverse team of collaborators, have launched an ambitious new project - dubbed the Cancer Cell Map Initiative or CCMI - to determine how all of the components of a cancer cell interact.

30 Jan 2015

Abbott's new TECNIS Multifocal IOLs now available in the U.S. for people with cataracts

Two new intraocular lenses (IOLs) that restore vision to people with cataracts are now available in the United States. The new TECNIS Multifocal IOLs, developed by Abbott, provide people with cataracts options to have a full range of near, intermediate and distance vision, while customizing their treatment based on their personal vision needs and lifestyle.

30 Jan 2015

OSTAR introduces Cellular TeleHealth Blood Pressure Monitoring System in North America

OSTAR Healthcare Technology, a Washington State Based TeleHealth Solutions company, announced the North American launch of yet another first in their Cellular TeleHealth Blood Pressure Monitoring System.

30 Jan 2015

ANI Pharmaceuticals launches Etodolac 300mg oral capsules

ANI Pharmaceuticals, Inc. today announced the launch of Etodolac 300mg oral capsules, indicated for use in the management of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and acute pain.

30 Jan 2015

Nuvo Research announces topline results from WF10 Phase 2 allergic rhinitis clinical trial

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced the results of its 16-week, double-blind, placebo-controlled, Phase 2 clinical trial conducted in Germany to compare the safety and efficacy of WF10 and its main constituents (sodium chlorite and sodium chlorate) with saline in patients with refractory allergic rhinitis and to compare the safety and efficacy of WF10 and its main constituents.

30 Jan 2015

Researchers move one step closer to treating diabetes with human probiotic pill

Science may be one step closer to treating diabetes with a human probiotic pill, according to new Cornell University research.

30 Jan 2015

Texting better than apps to treat people with mental illness

Texting may be a more suitable treatment aid for those with mental illness than mobile applications.

30 Jan 2015

Steroid use associated with five-fold increase of blood clots in IBD patients

Compared with biologic therapy, corticosteroid (steroid) use is associated with a nearly five-fold increase of venous thromboembolism in inflammatory bowel disease (IBD) patients, according to a new study1 in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

30 Jan 2015

Psychopath’s persistent violent behaviour associated with brain abnormalities

Psychopathic violent offenders have abnormalities in the parts of the brain related to learning from punishment, according to an MRI study led by Sheilagh Hodgins and Nigel Blackwood. "One in five violent offenders is a psychopath.

30 Jan 2015

Leading academics underscore the importance of diet and nutrition for mental Health

Evidence is rapidly growing showing vital relationships between both diet quality and potential nutritional deficiencies and mental health, a new international collaboration led by the University of Melbourne and Deakin University has revealed.

30 Jan 2015

TxCell receives milestone payment of EUR 1 million concerning Ovasave collaboration, license agreement from Trizell

TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today the receipt of the latest milestone payment of EUR 1 million from the Ovasave collaboration option, development and license agreement from Trizell (Trizell Holding SA).

30 Jan 2015

Farnesoid-X receptor could play key role in hepatobiliary and gastrointestinal disorders

The farnesoid-X receptor (FXR), also known as the chief regulator of bile acid metabolism, is thought to play a role in some hepatobiliary and gastrointestinal disorders.

30 Jan 2015

Unique project launched to identify effects of exercise on young people's hearts

A unique research project to identify the effects of exercise on young hearts has been announced today.

30 Jan 2015

Research reveals key protein structure, paves way for better anti-anxiety drugs

When new medicines are invented, the drug may hit the intended target and nullify the symptoms, but nailing a bull's eye - one that produces zero side effects - can be quite elusive.

30 Jan 2015

Immunotherapy expert discusses the concept of precision immunology and personalized medicine

With President Obama's recent State of the Union speech addressing the launch of a national precision medicine initiative to further tackle cancer and other diseases, a leading immunotherapy expert from Rutgers Cancer Institute of New Jersey weighs in on where we stand with precision immunology and personalized medicine and what needs to be accomplished.

30 Jan 2015

Study examines fear influenced colorectal cancer screening decisions in UK adults

People who worry about cancer are more likely to want to get screened for colon cancer, but feeling uncomfortable at the thought of cancer makes them less likely to actually go for the test, finds new UCL-led research.

30 Jan 2015

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat allergies induced by Japanese red cedar pollen.

30 Jan 2015

Medical Condition News

Shire announces FDA approval of Vyvanse Capsules for binge eating disorder

Using antioxidant to reverse brain inflammation improves obesity, diabetes symptoms

BTH to develop new technologies to improve quality of life for elderly people with mild dementia

UCSD, UCSF launch new project to map cancer cells

Abbott's new TECNIS Multifocal IOLs now available in the U.S. for people with cataracts

OSTAR introduces Cellular TeleHealth Blood Pressure Monitoring System in North America

ANI Pharmaceuticals launches Etodolac 300mg oral capsules

Nuvo Research announces topline results from WF10 Phase 2 allergic rhinitis clinical trial

Researchers move one step closer to treating diabetes with human probiotic pill

Texting better than apps to treat people with mental illness

Steroid use associated with five-fold increase of blood clots in IBD patients

Psychopath’s persistent violent behaviour associated with brain abnormalities

Leading academics underscore the importance of diet and nutrition for mental Health

TxCell receives milestone payment of EUR 1 million concerning Ovasave collaboration, license agreement from Trizell

Farnesoid-X receptor could play key role in hepatobiliary and gastrointestinal disorders

Unique project launched to identify effects of exercise on young people's hearts

Research reveals key protein structure, paves way for better anti-anxiety drugs

Immunotherapy expert discusses the concept of precision immunology and personalized medicine

Study examines fear influenced colorectal cancer screening decisions in UK adults

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News